201 related articles for article (PubMed ID: 28188377)
1. [Neuroendocrine neoplasia of the stomach : What is new?].
Knösel T; Reiter C; Schubert-Fritschle G; Altendorf-Hofmann A; Kirchner T
Pathologe; 2017 Mar; 38(2):98-104. PubMed ID: 28188377
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
3. [Gastric neuroendocrine tumors].
Alekberzade AV; Krylov NN; Lipnitskiy EM; Shakhbazov RO; Azari F
Khirurgiia (Mosk); 2019; (12):111-120. PubMed ID: 31825351
[TBL] [Abstract][Full Text] [Related]
4. [Consensus and controversy on subtype classification of gastric neuroendocrine neoplasms].
Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):977-981. PubMed ID: 28900986
[TBL] [Abstract][Full Text] [Related]
5. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
6. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
Lee HE; Mounajjed T; Erickson LA; Wu TT
Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
[TBL] [Abstract][Full Text] [Related]
7. Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors.
Solcia E; Rindi G; Paolotti D; Luinetti O; Klersy C; Zangrandi A; La Rosa S; Capella C
Yale J Biol Med; 1998; 71(3-4):285-90. PubMed ID: 10461359
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine tumors of the stomach. Pathogenesis, classification and clinical aspects].
Bordi C; Azzoni C; D'Adda T; Caruana P; Carlinfante G
Pathologe; 1997 Jul; 18(4):313-21. PubMed ID: 9380606
[TBL] [Abstract][Full Text] [Related]
9. Gastric neuroendocrine tumors.
Delle Fave G; Capurso G; Annibale B; Panzuto F
Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
[TBL] [Abstract][Full Text] [Related]
10. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
11. Classification and Prognostic Stratification of Bronchopulmonary Neuroendocrine Neoplasms.
Oka N; Kasajima A; Konukiewitz B; Sakurada A; Okada Y; Kameya T; Weichert W; Ishikawa Y; Suzuki H; Sasano H; Klöppel G
Neuroendocrinology; 2020; 110(5):393-403. PubMed ID: 31422400
[TBL] [Abstract][Full Text] [Related]
12. Gastric neuroendocrine neoplasms.
Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
[TBL] [Abstract][Full Text] [Related]
13. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
[TBL] [Abstract][Full Text] [Related]
14. The biological relevance of gastric neuroendocrine tumors.
Klöppel G; Clemens A
Yale J Biol Med; 1996; 69(1):69-74. PubMed ID: 9041691
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic aspects of gastric neuroendocrine tumors.
Rindi G
Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience.
Karakaş Y; Laçin Ş; Kurtulan O; Esin E; Sunar V; Sökmensüer C; Kılıçkap S; Yalçin Ş
Turk J Gastroenterol; 2020 Feb; 31(2):91-98. PubMed ID: 32141816
[TBL] [Abstract][Full Text] [Related]
17. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
18. Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study.
Panzuto F; Campana D; Massironi S; Faggiano A; Rinzivillo M; Lamberti G; Sciola V; Lahner E; Manuzzi L; Colao A; Annibale B
Dig Liver Dis; 2019 Oct; 51(10):1456-1460. PubMed ID: 31175013
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.
Vanoli A; La Rosa S; Miceli E; Klersy C; Maragliano R; Capuano F; Persichella A; Martino M; Inzani F; Luinetti O; Di Sabatino A; Sessa F; Paulli M; Corazza GR; Rindi G; Bordi C; Capella C; Solcia E
Neuroendocrinology; 2018; 107(2):114-126. PubMed ID: 29895024
[TBL] [Abstract][Full Text] [Related]
20. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
